TSLC1/IGSF4A is a tumor suppressor gene in non-small cell lung cancer (1, 2) , which encodes a single membrane-spanning glycoprotein belonging to the family of immunoglobulin superfamily cell adhesion molecules (3) . Because of its diverse functions in various tissues, TSLC1 has been characterized by several independent research groups. It is also known, therefore, as RA175 (4), SgIGSF (5), Necl2 (6) , and SynCAM1 (7) . In a primary non-small cell lung cancer, we have found a 2-bp deletion in the TSLC1 that causes replacement of the C-terminal 19 amino acid residues, indicating that the cytoplasmic domain of TSLC1 is crucial for tumor suppression (2) . In fact, the cytoplasmic domain was shown to be necessary for tumor suppressor activity of TSLC1 in nude mice (8) . The cytoplasmic tail of TSLC1 contains a juxtamembrane sequence interacting with protein 4.1binding motif (protein 4.1-BM) 4 and a class II PDZ binding motif (PDZ-BM) at the C terminus. We have demonstrated that protein4.1B/DAL-1, a member of the protein 4.1 family, connects TSLC1 to the actin cytoskeleton, and the interaction is involved in actin reorganization (9) . Along with others, we have reported that TSLC1 also interacts with membrane-associated guanylate kinase homologs (MAGuKs) through its class II PDZ domain (6, 7, 10) , implying that TSLC1, protein 4.1, and MAGuK form a tripartite complex. TSLC1 was originally identified based upon its ability to suppress tumorigenicity of human lung adenocarcinoma A549 cells in nude mice (2) . Restoration of TSLC1 expression in A549 cells inhibited the metastasis from the spleen to the liver (9) . Loss of TSLC1 has been observed at high frequency in advanced lung cancers as well as many other human cancers (2, 11) . Although these observations strongly suggest that the C-terminal motifs of TSLC1 play a crucial role in the suppression of tumor invasion and/or metastasis, as yet the precise roles of these motifs remain elusive.
Epithelial-mesenchymal transitions (EMT), in which polarized epithelial cells become motile fibroblast-like cells, occur during critical phases of normal embryonic development in multicellular organisms (12) . It has been known, however, that EMT contributes to invasion and metastasis of carcinoma cells from epithelial tumors (12, 13) . The 'scattering' of Madin-Darby canine kidney (MDCK) epithelial cells by HGF is one of the well documented in vitro model systems that have been used to study the mechanisms of EMT (12) . When exposed to HGF, MDCK cells grown as small colonies on tissue culture plates respond by spreading, dissociating from each other, and scattering away from the colonies (12) . HGF induces a vast array of signaling through its receptor, c-Met, and one clear downstream target is the cytoskeleton, which is dramatically rearranged in response to HGF (12) . During HGF-induced EMT, the Rho family GTPases, especially Rho and Rac, function as key mediators of actin cytoskeletal dynamics (14) . Another in vitro model involving EMT is HGF-induced MDCK tubulogenesis. A MDCK cell embedded in a collagen type I matrix forms a polarized lumen-enclosing epithelial monolayer called a cyst (15) . When treated with HGF, the cyst develops branching tubules. Although tubulogenesis is a complex morphogenic process, partial EMT involving rearrangements of the cytoskeleton and the junctional complexes between cells plays a key role at the stage where single file chains of cells are extended away from the cyst (15) .
In the present study using a series of truncation mutants, we examined the effect of TSLC1 on EMT in the MDCK-HGF model systems. The results suggest that TSLC1 suppresses the HGF-induced EMT through regulating the activation of small Rho GTPases.
EXPERIMENTAL PROCEDURES
Cells and Proliferation Assay-The MDCK Tet-Off cell line was obtained from BD Biosciences and maintained in Eagle's minimum essential medium (Sigma) supplemented with 100 M nonessential amino acids (Invitrogen), 1.0 mM sodium pyruvate (Invitrogen), 10% Tet system approved fetal bovine serum (BD Biosciences), 100 units/ml penicillin, and 100 g/ml streptomycin (Invitrogen). To suppress expression of the relevant gene, 0.1 g/ml of doxycycline (Dox) was added to the media. Cell growth was examined by MTS assay using a CellTiter 96 Aqueous nonradioactive cell proliferation assay kit (Promega) according to the manufacturer's protocol.
Antibodies-Rabbit polyclonal antibodies (pAb) against the C terminus of TSLC1 (CC2) (3) and the ectodomain of TSLC1 (EC) (8) were described previously. A rabbit anti-hemagglutinin (HA) pAb (sc-805) and a mouse anti-HA monoclonal antibody (mAb) clone 12CA5 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and Roche Applied Science, respectively. Mouse mAbs against ␤-catenin, E-cadherin (clone 36), and fibronectin were from BD Biosciences. Other mouse mAbs used were specific to ZO-1 (Zymed Laboratories Inc.) and vimentin (clone V9, Sigma). Secondary antibodies for immunoblot analysis and immunofluorescence staining were from Amersham Pharmacia Biotech and Jackson ImmunoResearch Lab (West Grove, PA), respectively. Antibodies used for the Rac and Rho activation assay were a mouse anti-Rac1 mAb, clone 23A8, and a rabbit anti-Rho pAb (Upstate, Lake Placid, NY), respectively.
Expression Vectors and Transfection-To obtain pTRE2/TSLC1, TSLC1 cDNA was cloned into a pTRE2hygro vector (BD Biosciences). Truncated TSLC1 fragments were generated by PCR using pTSLC1-HA (3) or pcTSLC1 (3) as a template and cloned into a pTRE2 hygro vector. To generate a mutant lacking the cytoplasmic tail of TSLC1 (⌬C-HA), the amino acid residues positioned from 397 to 442 were removed, and the residue at 396 was fused with an HA epitope tag (Fig. 1A) . The truncation mutants ⌬4.1-BM and ⌬PDZ-BM were designed to remove 11 amino acids (400 -410) encompassing the protein 4.1-BM and 4 amino acids (439 -442) containing the PDZ-BM, respectively (Fig. 1A) . These constructs were transfected into the cells with FuGENE 6 reagent (Roche Applied Science) according to the manufacturer's protocol. Stable clones were selected in medium containing 300 g/ml of hygromycin (Invitrogen).
Protein Analysis-Preparation of cell lysates and immunoblot analysis were described previously (9) . Gel was stained with Simply Blue Safestain (Invitrogen) when needed.
Three-dimensional Culture in Collagen Gels and Tubulogenesis Assay-A three-dimensional culture was carried out according to the manufacturer's instructions (Nitta Gelatin, Osaka, Japan). Cells were added to the collagen I mixture, gently mixed, and plated onto 12-well plates at 5 ϫ 10 3 cells/well. Five-day-old cysts were examined for general cyst architecture and subcellular localization of the full-length TSLC1 and the deletion mutants. For induction of tubulogenesis, 4-day-old cysts were stimulated with fresh medium containing 40 ng/ml recombinant HGF (Sigma), incubated for 4 additional days, and examined by phasecontrast microscopy. All images were taken with a Nikon Eclipse inverted microscope TE300 (Tokyo, Japan) equipped with a cooled CCD digital camera. To quantitate tubulogenesis, the area of cysts and tubules was calculated with NIH Image software.
Cell Scattering Assay-Cells were seeded at 1 ϫ 10 4 cells/well in 6-well culture plates. On the next day, the cells were fed with fresh medium in the presence or absence of 40 ng/ml HGF and incubated for another 17 h. Cell scattering was examined by phase-contrast microscopy and photographed as described above. Cell scattering was quantified by counting the number of isolated cells from colonies and the total number of cells in randomly selected phase-contrast images.
Immunostaining and Confocal Microscopy-For the two-dimensional polarity experiments, cells were seeded at a density of 1 ϫ 10 5 cells/24 mm Trans-well COL collagen-coated filter insert (Costar, Cambridge, MA) and allowed to grow to confluence for 5-6 days. The cells were fixed and immunostained as described previously (3) . Then the stained cells were examined with a Bio-Rad Radiance 2000 laser confocal scanning system equipped with a 488/514-nm argon and a 543-nm helium-neon laser. The X-Z vertical sections were generated with a 0.2-m motor step. Each image represents a single averaged (32-line scan) image. When staining for nuclear DNA, TOTO-3 iodide (Invitrogen) was added to the solution containing secondary antibodies. Immunofluorescent staining of the cysts in collagen type I gel was carried out as described previously (16) .
Rac and Rho Activation Assay-Activation of Rac and Rho was determined by a glutathione S-transferase (GST) pull-down assay using a Rac activation assay kit and a Rho activation kit (Upstate), respectively, according to the manufacturer's protocol. Briefly, cells were seeded at 1 ϫ 10 5 cells/100-mm culture plate and serum-starved overnight. Then, the cells were stimulated with 40 ng/ml HGF for various time periods and lysed in an MLB lysis buffer. Rac-GTP and Rho-GTP were precipitated from the lysates with the GST-tagged p21-activated kinase (PAK)-Rac binding domain (RBD) and the GST-tagged Rhotekin-Rho binding domain (RBD) immobilized on glutathione-agarose beads, respectively. Total lysates and precipitates were analyzed by immunoblot analysis. Densitometric analyses were performed using NIH Image software.
Statistics-Statistical analysis was performed, where appropriate, using the Wilcoxon rank sum test or Student's t test.
RESULTS

Isolation of Inducible Cell Clones Expressing Wild-type or Truncated
TSLC1-MDCK Tet-Off cells, which express the tetracycline-repressible transactivator, were transfected with plasmids encoding the wildtype or truncated TSLC1 (Fig. 1A) , and Dox-inducible clones were established. As a control, clones expressing GFP were also prepared. Immunoblot analysis has revealed that the obtained clones express the transgenes at a nearly equivalent level (Fig. 1B, lanes 3, 5, 7, 9, and 11) . MDCK Tet-Off cells express a low level of endogenous TSLC1 detected as faint bands in Fig. 1B (lanes 1 and 2) . Expression of the transgenes was tightly regulated with Dox in the established clones (Fig. 1B, lanes 3-12) . A cell proliferation assay of the clones showed growth comparable with that of parental MDCK cells (Fig. 1C) , indicating that overexpression of TSLC1 or any of the truncation mutants does not alter cell growth in MDCK cells (Fig. 1C) .
Both the Protein 4.1-BM and the PDZ-BM Are Necessary for the Lateral Localization of TSLC1 in Cysts Grown in a Three-dimensional
Culture-We have previously reported that TSLC1 distributes to the lateral membrane of polarized cells on permeable supports (3). We tested whether deletion of the cytoplasmic domain or the conserved motifs affects its lateral localization. Except for punctate signals detected in the cytosol of the cells expressing the deletion mutants, all the truncated forms of TSLC1 were concentrated to the lateral surface of the cells, as seen in cells expressing the wild-type TSLC1 (Fig. 2) . In the three-dimensional extracellular matrix, MDCK cells form hollow cysts that are lined by a monolayer of the cells (15) . We embedded each of the clones in collagen I gel and found that all of them formed cysts that were morphologically indistinguishable from the one derived from the parental MDCK cell (Fig. 3 and 4, left columns) . Immunofluorescence microscopy demonstrated that TSLC1 was localized to the lateral membrane (Fig. 3, e and f) , whereas ⌬C-HA was detected diffusely in the cytoplasm (Fig. 3, i and j) , indicating that the truncation of the entire cytoplasmic domain abolished the lateral localization of TSLC1. Although a large fraction of ⌬4.1-BM distributed to the lateral membrane, it was also detected in the apical side of the cytosol (Fig. 3, m and  n) . Intriguingly, deleting PDZ-BM shifted its localization from the lateral surface to the bottom third of the lateral membrane and the basal surfaces (Fig. 3, q and r) . We have also stained the cysts for ZO-1, a marker of tight junctions, which is normally detected on the apical surfaces facing inwards of parental MDCK cysts (15) . In the cysts expressing the wild-type or truncated TSLC1, ZO-1 was detected as dots delineating the interior luminal free space of the cysts (Fig. 3, c, g, k , o, and s), indicating that expression of TSLC1 or any of the truncated mutants did not affect orientation of cell polarity.
Expression of TSLC1 in MDCK Cells Suppressed HGF-induced Tubulogenesis-We then assessed whether the overexpression of TSLC1 affects HGF-induced tubulogenesis. In collagen I gel, parental MDCK cells and the cells expressing GFP, TSLC1, ⌬C-HA, ⌬4.1-BM, or ⌬PDZ-BM developed cysts in a similar size (Fig. 4, left column) . The presence of Dox did not affect either the development of cysts from each clone (data not shown) or tubulogenesis of parental MDCK cells (Fig. 4,  b and c) . When cultured with HGF for 4 days, tubulogenesis was induced in parental MDCK and MDCK/GFP cysts (Fig. 4, b and e) . In contrast, mature tubules were rarely observed in the MDCK/TSLC1 cysts (Fig. 4h) , although magnified phase-contrast images revealed multiple short extensions from the basal membrane (Fig. 4h, inset) . When TSLC1 expression was repressed with Dox in MDCK/TSLC1 cells, tubulogenesis reverted to the level comparable with that of the parental MDCK cells (Fig. 4i) . Furthermore, MDCK/⌬C-HA, MDCK/⌬4.1-BM, and MDCK/⌬PDZ-BM cysts formed tubules in a size similar to that observed in parental MDCK cysts (Fig. 4, b, k, n, and q) . Quantitative analysis of 30 cysts for each cell clone demonstrated that the difference in tubulogenesis between the Dox-treated (TSLC1 off) and untreated (TSLC1 on) MDCK/TSLC1 cells was statistically significant (p Ͻ 0.0001), whereas other cell clones showed no statistically significant difference between the Dox-treated and untreated cysts (p Ͼ 0.05) (Fig.  5) . These findings indicate that TSLC1 expression, indeed, blocks HGFinduced tubulogenesis and that either of the cytoplasmic motifs is indispensable for the inhibitory effect.
TSLC1 Inhibits HGF-induced Cell Scattering by Suppressing Induction of EMT-We next examined the effects of TSLC1 on HGF-induced cell scattering of MDCK cells. In the absence of HGF, all the cell clones formed small colonies on plastic two-dimensional substrata, which were morphologically indistinguishable from one another (Fig. 6, left  column) . The presence of Dox did not affect either the morphology of each clone (data not shown) or scattering of parental MDCK cells (Fig.  6, b and c) . After a 17-h incubation with HGF, MDCK, MDCK/GFP, and MDCK/⌬C-HA cells exhibited a spindle-like fibroblastic morphology and scattered across a culture plate at a comparable level (Fig. 6, b, e, and  k) . On the other hand, the HGF-treated MDCK/TSLC1 cells did not dissociate from each other and showed flattened morphology (Fig. 6h ) compared with the tightly compacted cobblestone-like morphology seen before adding HGF (Fig. 6g) . When TSLC1 expression was repressed with Dox, MDCK/TSLC1 cells scattered (Fig. 6i ) similar to the parental MDCK cells (Fig. 6c) . HGF also induced scattering of -d, f-h, j-i, n-p, and r-t) are also shown. Bars, 10 m. (Fig. 6, n and q) , although the degree of scattering in MDCK/⌬4.1-BM cells (Fig. 6n) was slightly lower than in parental MDCK cells (Fig. 6b) . A quantitative analysis of cell scattering confirmed that the difference between the Dox-treated and untreated MDCK/TSLC1 cells was statistically significant with p Ͻ 0.0001. In contrast, other cell clones showed no significant difference between the Dox-treated and untreated cells (p Ͼ 0.05) (Fig. 7) .
MDCK/⌬4.1-BM and MDCK/⌬PDZ-BM cells
To determine whether molecular changes of EMT occurred in these cells, we examined localization of adherens junction (AJ) proteins and markers for mesenchymal cells in parental MDCK, MDCK/TSLC1, and MDCK/⌬C-HA cells after a 17-h incubation with or without HGF. In the absence of HGF, all the small colonies from each clone were stained for the AJ proteins, E-cadherin and ␤-catenin, at the cell-cell boundaries (Fig. 8A, b, c, g, h, l, and m) , but not for the mesenchymal markers, vimentin and fibronectin (Fig. 8A, d, e, i, j, n, and o) . In HGF-treated MDCK and MDCK/⌬C-HA cells, ⌬C-HA (Fig. 8A, kЈ) , E-cadherin (Fig.  8A, bЈ and lЈ) , and ␤-catenin (Fig. 8A, cЈ and mЈ) disappeared from the cell membrane. Instead, these cells expressed vimentin (Fig. 8A , dЈ and nЈ) and fibronectin (Fig. 8A, eЈ and oЈ) , reflecting that they underwent EMT. In contrast, HGF-treated MDCK/TSLC1 cells continued to express TSLC1 (Fig. 8A, f Ј) , E-cadherin (Fig. 8A, gЈ) , and ␤-catenin (Fig.   8A, hЈ) at the cell-cell attached sites, but no mesenchymal marker (Fig.  8A, iЈ and jЈ) was observed.
We also tested the expression of these proteins by immunoblot analysis (Fig. 8B) . Consistent with the results of immunofluorescence staining, expression of vimentin and fibronectin was induced in HGF-treated MDCK and MDCK/⌬C-HA cells but not in MDCK/TSLC1 cells (Fig.  8B) . The expression of E-cadherin was reduced in HGF-treated MDCK and MDCK/⌬C-HA cells but not in HGF-treated MDCK/TSLC1 cells (Fig. 8B) indicating that MDCK/TSLC1 cells retained E-cadherin-based cell-cell adhesion even after being treated with HGF. These results suggest that TSLC1 abrogates the induction of EMT and maintains the epithelial phenotype in HGF-treated MDCK cells. Although the signal of ␤-catenin was not detected in either the HGF-treated MDCK (Fig.  8A, cЈ) or MDCK/⌬C-HA (Fig. 8A, mЈ) cells by immunostaining, the amount of ␤-catenin was not decreased in these cells by immunoblot analysis (Fig. 8B) . ␤-Catenin has been reported to translocate from the membrane to the cytosol and/or nucleus when E-cadherin-based cell adhesion is disrupted (12) . This translocation is likely to have made the immunostaining signal of ␤-catenin weaker in our study.
TSLC1 Modulates Rac and Rho Activities in HGF-treated MDCK Cells-The
Rho family GTPases are well known key mediators of actin cytoskeletal rearrangements during HGF-induced cell scattering and tubulogenesis (17) . A previous study has demonstrated that, in MDCK cells on a tissue culture plate, HGF elicits transient immediate early activation of Rac and sustained activation of Rho, which is correlated with cell scattering response (18) . With use of GST-RAK-RBD and GST-Rhotekin-RBD agarose beads, we confirmed that in response to HGF, the parental cells showed immediate early increase in Rac activity, which returned to basal levels within 15 min (Fig. 9A, left panel) , as well as sustained Rho activation (Fig. 9B, left panel) . In contrast, the HGFtreated MDCK/TSLC1 cells exhibited prolonged Rac activation, which was still observed 4 h after stimulation (Fig. 9A, middle panel) , but there was no increase in Rho activity (Fig. 9B, middle panel) . These results demonstrated that the expression of TSLC1 induces the prolonged activation of Rac and the reduced activation of Rho in HGF-stimulated MDCK cells. It is, therefore, conceivable that the ability of TSLC1 to block the HGF-triggered cell scattering may arise from its modulatory effects on Rac and Rho activities. The regulatory effect of TSLC1 on Rac activity appeared to depend upon its cytoplasmic domain because MDCK/⌬C-HA cells showed a profile of Rac activation (Fig. 9A , right panel) similar to that in parental MDCK cells (Fig. 9A, left panel) . ⌬C-HA, however, did not completely restore the sustained activation of Rho (Fig. 9B, right panel) to the level observed in parental MDCK cells (Fig. 9B, left panel) .
DISCUSSION
To elucidate the molecular mechanisms of tumor and/or metastasis suppression by TSLC1, we investigated the effects of TSLC1 on EMT in MDCK-HGF models using a series of truncated mutants along with their subcellular localization. In a three-dimensional culture, but not in a two-dimensional culture, we found that both the protein 4.1-BM and the PDZ-BM were indispensable for the lateral localization of TSLC1. Because three-dimensional culture systems are known to resemble the in vivo environment more closely than two-dimensional culture systems (19) , both the protein 4.1-BM and the PDZ-BM could play vital roles in the lateral localization of TSLC1 in human epithelium. Compared with the protein 4.1-BM, truncation of the PDZ-BM showed more striking effects on subcellular localization of TSLC1. Deleting the PDZ-BM shifted the localization from the lateral membrane to the basal surface of the MDCK cysts. The PDZ-BM of TSLC1 has been shown to interact with MAGuKs that act as molecular scaffolds (6, 7, 10) . The result raises the intriguing possibility that MAGuKs are involved in lateral targeting of TSLC1 or retention of TSLC1 in the lateral membrane.
In MDCK-HGF models, we have demonstrated that expression of TSLC1 suppresses HGF-induced tubulogenesis and cell scattering and that either the protein 4.1-BM or the PDZ-BM is necessary for this inhibition. The inhibitory effect of tubulogenesis appeared to be correlated with the lateral localization of TSLC1 in cysts. HGF-induced tubulogenesis of MDCK cells proceeds through four distinct stages: (I) formation of extensions, (II) formation of single file cell chains, (III) conversion to multilayered cords, and (IV) maturation of tubules (19) . A number of thin extensions were observed in the HGF-stimulated MDCK/TSLC1 cysts by phase-contrast microscopy, implying that TSLC1 might exert its inhibitory effect at stage II. It has been suggested that partial EMT occurs during stage I and II to form extensions and chains (19) . TSLC1 would, therefore, suppress the induction of EMT during HGF-induced tubulogenesis.
HGF-induced cell scattering of MDCK cells is also subdivided into three major stages: (I) cell spreading, (II) dissociation of cells from each other, and (III) migration as individual cells. HGF-treated MDCK/ TSLC1 cells showed flattened morphology but did not dissociate from each other, suggesting that TSLC1 might inhibit the process in stage II. Furthermore, we found that MDCK/TSLC1 cells continued to express AJ proteins at cell-cell boundaries, but not mesenchymal markers after stimulation with HGF. Consequently, TSLC1 expression could maintain an epithelial phenotype of MDCK cells by abrogating EMT induced by HGF. It has been suggested that Rac and Rho are involved in HGFtriggered cell scattering at different stages (14) . Previous studies from others have shown that a constitutively active Rac mutant abolishes HGF-mediated scattering (17, 20) and high in Rac and low in Rho activities are correlated with an epithelial phenotype by stabilizing E-cadherin-dependent cell-cell adhesion (20, 21) . Consistent with these earlier reports, we observed high Rac and low Rho activities along with stabilization of cell-cell adhesion in the HGF-treated MDCK/TSLC1 cells. It seems, therefore, that TSLC1 abolishes HGF-induced EMT of MDCK cells by inducing sustained activation of Rac and low activity of Rho. Sequential analysis of Rac activity during HGF-induced MDCK cell scattering showed that a transient decrease in Rac activity seemed necessary to elicit cell-cell dissociation (22) . Given that a transient decrease in Rac activity is essential to induce disassembly of cell-cell junctions, prolonged Rac activation seen in the HGF-treated MDCK/ TSLC1 cells may interfere with the process of cell dissociation, thereby inhibiting cell scattering. The regulatory effect of TSLC1 on Rac activity appeared to depend upon its cytoplasmic domain. In addition, the protein 4.1-BM and PDZ-BM, which both locate in the cytoplasmic domain, are indispensable for the inhibitory effects of TSLC1 on tubulogenesis and cell scattering. It is plausible, therefore, that proteins interacting with these motifs may be responsible for the prolonged Rac activation induced by TSLC1. We noted, however, that the HGFtreated ⌬C-HA/MDCK cells did not show the prolonged Rho activation at the level observed in parental MDCK cells. This suggests that downregulation of Rho activity caused by TSLC1 required another domain of TSLC1 besides its cytoplasmic domain.
Epigenetic silencing of TSLC1 is frequently observed in advanced non-small cell lung cancer as well as in many other human cancers, reflecting its involvement in invasion and/or metastasis (2, 11) . Consistent with this, restoration of TSLC1 expression in TSLC1-deficient nonsmall cell lung cancer cells dramatically suppressed metastasis from the spleen to the liver in nude mice (9) . In addition, immunohistochemical studies of primary lung adenocarcinomas demonstrated that TSLC1-positive tumor cells tended to be less invasive (23) (24) (25) . All these observations suggest that the loss of TSLC1 is involved in EMT during tumor cell invasion and/or metastasis in various advanced human tumors. The present study in in vitro systems supports the idea that TSLC1 suppresses induction of EMT by modulating the activities of Rac and Rho. Investigations on how TSLC1 induces high Rac and low Rho activity in HGF-stimulated MDCK cells are now underway. It also should be noted that we did not detect the association between TSLC1 and the receptor for HGF, c-Met, by a coimmunoprecipitation assay (data not shown). Further studies will provide pivotal information toward understanding the signaling involved in the tumor-suppressive activity of TSLC1 and also may establish a mechanistic link between TSLC1, EMT, and tumor metastasis. 
